Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/2014
12/10/2014CN104203924A 杂环化合物及其作为抗癌药的用途 Heterocyclic compounds and their use as anticancer agents
12/10/2014CN102766103B 2-硫代-4-胺基-1-萘酚衍生物、其制备方法和用途 2- thioxo-4-amino-1-naphthol derivatives, their preparation and use
12/10/2014CN102532137B 8-吡唑取代黄嘌呤类a2b腺苷受体拮抗剂及其合成方法和应用 8- pyrazole substituted xanthine a2b adenosine receptor antagonists and synthesis method and application
12/10/2014CN102264739B 中间体和应用所述中间体制备恩替卡韦的方法 Intermediates for the preparation of intermediates and applying the method of entecavir
12/10/2014CN102176911B 新的腺嘌呤衍生物 New adenine derivatives
12/10/2014CN101437823B 多晶型 Polymorph
12/09/2014US8907086 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
12/04/2014US20140357646 Polymorphs
12/02/2014US8901308 Triazole compounds that modulate Hsp90 activity
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901135 Heterocyclic compounds and their uses
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901119 Peptide deformylase inhibitors
11/2014
11/25/2014US8895747 Method and substances for preparation of N-substituted pyridinium compounds
11/25/2014US8895741 Process for the synthesis of biaryl oxazolidinones
11/25/2014US8895580 Quinolinone-pyrazolone M1 receptor positive allosteric modulators
11/25/2014US8895570 Purine derivatives
11/25/2014US8895569 Carbocyclic nucleosides and their pharmaceutical use and compositions
11/25/2014US8895245 Inhibitors of human EZH2 and methods of use thereof
11/20/2014US20140343057 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
11/20/2014US20140343033 Azaindole derivatives
11/20/2014US20140341894 Certain chemical entities, compositions and methods
11/18/2014US8889861 Crystalline forms of a purine derivative
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889677 Substituted triazoles useful as mGlu5 receptor modulators
11/13/2014US20140336175 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
11/13/2014US20140336166 Novel purine derivatives and their use in the treatment of disease
11/11/2014US8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
11/11/2014US8883800 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
11/06/2014US20140330015 Purinone derivative hydrochloride
10/2014
10/30/2014US20140323728 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
10/30/2014US20140323448 sGC STIMULATORS
10/30/2014US20140323441 Purine derivatives for the treatment of viral infections
10/30/2014US20140323439 Therapies for hematologic malignancies
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871775 Compounds
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/21/2014US8865896 Method for preparing adenine compound
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865730 Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
10/21/2014US8865713 Benzoimidazoles as prolyl hydroxylase inhibitors
10/21/2014US8865677 iRNA agents with biocleavable tethers
10/16/2014US20140309419 Method for enhancing the thermal stability of ionic compounds
10/16/2014US20140309212 Bruton's tyrosine kinase inhibitors
10/14/2014US8859566 Substituted fused pyrimidine compounds
10/14/2014US8859490 Peptide nucleic acid monomers and oligomers
10/09/2014US20140303194 Salt forms of organic compound
10/09/2014US20140303193 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/09/2014US20140303192 Compounds and compositions for treating chemical warfare agent-induced injuries
10/09/2014US20140303177 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/09/2014US20140303151 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
10/09/2014US20140303112 Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2785723A1 Difluoromethylation of unsaturated compounds
10/08/2014EP2785696A1 Novel compounds
10/02/2014WO2014154921A1 Method for the synthesis of homologous compounds of azanucleosides
10/02/2014WO2014154859A1 Macrocyclic deaza-purinones for the treatment of viral infections
10/02/2014US20140296520 Process for the preparation of valacyclovir hydrochloride
10/02/2014US20140296263 Substituted xanthine derivatives
10/02/2014US20140296261 Kinase modulating compounds, compositions containing the same and use thereof
10/02/2014US20140296260 3-Aryl-2-((Arylamino)Methyl)Quinazolin-4-(3H)-Ones
10/02/2014US20140296207 Heterocyclic compounds and uses thereof
09/2014
09/30/2014US8846948 Compounds
09/30/2014US8846697 Purine analogs
09/30/2014US8846696 Purine derivatives
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846682 Compound suitable for the treatment of synucleopathies
09/30/2014US8846636 Nucleoside analogues with quaternary carbon stereogenic centers and methods of use
09/25/2014WO2014153001A1 Combination therapy for treating cancer
09/25/2014WO2014152158A1 Theobromine compositions useful for increasing fetal weight gain and enhancing bone properties
09/25/2014WO2014151630A2 Compounds and compositions for the treatment of parasitic diseases
09/25/2014WO2014149208A1 Purine-based pesticidal compositions and related methods
09/25/2014US20140288099 Composition
09/24/2014EP2780341A1 Kinase modulating compounds, compositions containing the same and use thereof
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/18/2014US20140275528 Substituted xanthines and methods of use thereof
09/18/2014US20140275508 Artificial nucleic acids
09/18/2014US20140275128 Method of providing ocular neuroprotection
09/18/2014US20140275071 Substituted xanthines and methods of use thereof
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275013 Compounds and compositions for the treatment of parasitic diseases
09/17/2014EP2776439A1 Purine derivatives for the treatment of viral infections
09/17/2014EP2776438A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections
09/17/2014EP2776070A1 Immunomodulatory conjugates
09/16/2014US8835630 Acyclic nucleoside phosphonate diesters
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835420 Azaindole derivatives
09/16/2014CA2574220C Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
09/12/2014WO2014135507A1 Novel pyrazol derivatives
09/12/2014WO2014135473A1 Inhibitors of bruton's tyrosine kinase
09/12/2014WO2014135245A1 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents
09/12/2014WO2014134750A1 2,6,9-trisubstituted purine derivative and preparation method and use thereof
09/11/2014US20140256722 Benzoimidazoles as prolyl hydroxylase inhibitors
09/11/2014US20140256668 Substituted pyrrolo]2,3-d]pyrimidines
09/10/2014EP2773641A1 Biaryl ether sulfonamides and their use as therapeutic agents
09/09/2014US8829012 CDK inhibitors
09/09/2014US8828990 N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use
09/04/2014US20140249166 Methods of treating patients suffering from movement disorders
09/03/2014EP2771343A1 Methyltransferase inhibitors for treating cancer
09/03/2014EP2771342A1 Novel purine derivatives and their use in the treatment of disease
1 2 3 4 5 6 7 8 9 10 11 12 ... 120